Hepion Pharmaceuticals Inc logo

Hepion Pharmaceuticals Inc Share Price Today (NASDAQ: HEPA)

Hepion Pharmaceuticals Inc share price is $0.06 & ₹5.16 as on 11 May 2025 IST

$0.06

▲

-0.08

(-57.14%)

Live

Bell Icon

The stock has been delisted from the stock exchange on 12 May 2025

View live Hepion Pharmaceuticals Inc share price in Dollar and Rupees. Guide to invest in Hepion Pharmaceuticals Inc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Hepion Pharmaceuticals Inc, along with analyst recommendations, forecasts, and comprehensive financials.

Hepion Pharmaceuticals Inc (HEPA) Key Statistics

in dollars & INR

Previous Close
$0.14
Open
$0.39
Market Capitalization
$8.2M
Today's Volume
$4.0M
Revenue TTM
$0.0
EBITDA
$-19.3M
Earnings Per Share (EPS)
$-2278.66
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-487.03%

How to invest in Hepion Pharmaceuticals Inc Stock (HEPA) from India?

It is very easy for Indian residents to invest directly in Hepion Pharmaceuticals Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Hepion Pharmaceuticals Inc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Hepion Pharmaceuticals Inc or HEPA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Hepion Pharmaceuticals Inc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Hepion Pharmaceuticals Inc shares which would translate to 14.344 fractional shares of Hepion Pharmaceuticals Inc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Hepion Pharmaceuticals Inc, in just a few clicks!

Global Institutional Holdings in Hepion Pharmaceuticals Inc

  • Anson Funds Management LP

    0.43%

  • BlackRock Inc

    0.15%

  • Vanguard Group Inc

    0.09%

  • Geode Capital Management, LLC

    0.08%

  • Susquehanna International Group, LLP

    0.05%

  • Renaissance Technologies Corp

    0.03%

Analyst Recommendation on Hepion Pharmaceuticals Inc

Rating
Trend

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Hepion Pharmaceuticals Inc(by analysts ranked 0 to 5 stars)

About Hepion Pharmaceuticals Inc

Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatment for hepatocellular carcinoma (HCC) and other chronic liver diseases in the United States. It develops Rencofilstat, a therapeutic drug candidate that binds and inhibits the function of a specific class of isomerase enzymes called cyclophilins that regulates protein folding, as well as preclinical experiments of Rencofilstat reflects decreased liver fibrosis; liver inflammation; liver tumor burden; and titers of HBV, HCV, HDV, and HIV-1. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Morristown, New Jersey.
Organization
Hepion Pharmaceuticals Inc
Employees
0
CEO
Mr. John Patrick Brancaccio C.P.A.
Industry
Health Technology

Management People of Hepion Pharmaceuticals Inc

NameTitle
Mr. John Patrick Brancaccio C.P.A.
Interim CEO, Interim CFO & Chairman of the Board
Sharen Pyatetskaya
Director of Investor Relations

Important FAQs about investing in HEPA Stock from India :

Can Indians buy Hepion Pharmaceuticals Inc shares?

Yes, Indians can invest in the Hepion Pharmaceuticals Inc (HEPA) from India.

With INDmoney, you can buy Hepion Pharmaceuticals Inc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Hepion Pharmaceuticals Inc at zero transaction cost.

How can I buy Hepion Pharmaceuticals Inc shares from India?

It is very easy to buy Hepion Pharmaceuticals Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Hepion Pharmaceuticals Inc (HEPA) be purchased?

Yes, you can buy fractional shares of Hepion Pharmaceuticals Inc with INDmoney app.

What are the documents required to start investing in Hepion Pharmaceuticals Inc stocks?

To start investing in Hepion Pharmaceuticals Inc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is today's market capitalisation of Hepion Pharmaceuticals Inc?

Today's market capitalisation of Hepion Pharmaceuticals Inc HEPA is 8.2M

Who is the Chief Executive Officer (CEO) of Hepion Pharmaceuticals Inc ?

Mr. John Patrick Brancaccio C.P.A. is the current Chief Executive Officer (CEO) of Hepion Pharmaceuticals Inc.